MoonLake Immunotherapeutics has kicked off a year of readouts for its much-hyped inflammatory disease prospect with a ...
PeptiDream Announces Promising Pre-Clinical Results of Proprietary Oral IL-17A and IL-17F Dual Inhibitor with Biologic-Like Efficacy for the Treatment of Psoriasis PeptiDream Inc., a public Kanagawa, ...
ROCKFORD, Ill. — The Rockford Democrat running against Rep. Eric Sorensen in Illinois' 17th Congressional District primaries has had his campaign derailed after receiving an objection to his candidacy ...
Janssen Pharmaceutica NV has identified interleukin-17A (IL-17A)/IL-17 receptor A (IL-17RA) interaction inhibitors reported to be useful for the treatment of psoriasis, rheumatoid arthritis, ...
CHICAGO — In patients with axial spondyloarthritis (axSpA) who do not respond to an initial TNF inhibitor, switching to an interleukin (IL)-17 inhibitor was not superior to trying a second TNF ...
Beijing Innocare Pharma Tech Co. Ltd. and Innocare Pharma Ltd. have identified compounds acting as interleukin-17A (IL-17A)/interleukin-17 receptor A (IL-17RA) interaction, interleukin-17A/A (IL17A/A) ...
In a study published in Nature Immunology on January 6, a research team led by Prof. Qian Youcun from the Shanghai Institute of Nutrition and Health (SINH) of the Chinese Academy of Sciences ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results